Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy in Patients With NSAIDs and Low Dose Steroid: A Single-center, Randomized, Open Labeled, Pilot Study

NCT04885751 is registered in ClinicalTrials.gov with Seoul National University Boramae Hospital as lead sponsor.

NCT NCT04885751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy in Patients With NSAIDs and Low Dose Steroid: A Single-center, Randomized, Open Labeled, Pilot Study
Lead sponsor
Seoul National University Boramae Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2021
Completion date
January 31, 2022
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, enteritis, gastric ulcer, nsaid (non-steroidal anti-inflammatory drug) induced enteropathy, nsaid-associated gastropathy, osteoarthritis, other musculoskeletal disorder, rheumatoid arthritis